- A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Logothetis, L., Mylonas, I.A., Baloyannis, S., Pashalidou, M., Orologas, A., Zafeiropoulos, A., Kosta, V., Theoharides, T.C. International journal of immunopathology and pharmacology. (2005)